Discovery of a sulfated tetrapeptide that binds to vascular endothelial growth factor

Acta Biomaterialia

Volumn 1, Issue 4, 2005, Pages 451-459

  Maynard, Heather D ^a,c   Hubbell, Jeffrey A ^a,b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b EPFL   (Switzerland)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Heparin mimic; Library; Sulfated peptide; VEGF

Indexed keywords

BINDING ENERGY; BIOMATERIALS; ENDOTHELIAL CELLS; FLUORESCENCE; POLYSACCHARIDES; SURFACE PLASMON RESONANCE; SYNTHESIS (CHEMICAL);

BUILDING BLOCKES; GROWTH FACTOR; HEPARIN BINDING GROWTH FACTORS; HEPARIN MIMIC; MATRIX; SULFATED GLYCOSAMINOGLYCANS; SULPHATED PEPTIDE; SYNTHETIC BIOMATERIALS; TETRA PEPTIDE; VASCULAR ENDOTHELIAL GROWTH FACTOR;

PEPTIDES;

7 AMINO 4 METHYLCOUMARIN; 9 FLUORENYLMETHYL CHLOROFORMATE; BIOMATERIAL; COUMARIN DERIVATIVE; HEPARIN; PEPTIDE LIBRARY; RESIN; SURAMIN; TETRAPEPTIDE; UNCLASSIFIED DRUG; VASCULOTROPIN;

ARTICLE; BINDING AFFINITY; BINDING ASSAY; CHEMICAL ANALYSIS; COMBINATORIAL CHEMISTRY; CONTROLLED STUDY; FLUORESCENCE ANALYSIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; SIGNAL PROCESSING; SOLID PHASE SYNTHESIS; SULFONATION; SURFACE PLASMON RESONANCE;

EID: 33644804663     PISSN: 17427061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actbio.2005.04.004     Document Type: Article

References (61)

1. H. Engelberg Actions of heparin that may affect the malignant process Cancer 85 1999 257-272
2. J.W. Kehoe C.R. Bertozzi Tyrosine sulfation: A modulator of extracellular protein-protein interactions Chem Biol 7 2000 R57-R61
3. R.L. Jackson S.J. Busch A.D. Cardin Glycosaminoglycans: Molecular properties, protein interactions, and role in physiological processes Physiol Rev 71 1991 481-539
4. I. Capila R.J. Linhardt Heparin-protein interactions Angew Chem Int Ed 41 2002 390-412
5. A.N. Plotnikov J. Schlessinger S.R. Hubbard M. Mohammadi Structural basis for FGF receptor dimerization and activation Cell 98 1999 641-650
6. M.E. Nimni Polypeptide growth factors: Targeted delivery systems Biomaterials 18 1997 1201-1225
7. M.P. Lutolf J.A. Hubbell Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering Nature Biotechnol 23 2005 27-55
8. S.E. Saikyama-Elbert J.A. Hubbell Functional biomaterials: Design of novel biomaterials Ann Rev Mater Res 31 2001 183-201
9. E.R. Edelman E. Mathiowitz R. Langer M. Klagsbrun Controlled and modulated release of basic fibroblast growth factor Biomaterials 12 1991 619-626
10. G.C.M. Steffens C. Yao P. Prével M. Markowicz P. Schenck E.M. Noah et al. Modulation of angiogenic potential of collagen matrices by covalent incorporation of heparin and loading with vascular endothelial growth factor Tissue Eng 10 2004 1502-1509
11. S.E. Sakiyama-Elbert J.A. Hubbell Development of fibrin derivatives for controlled release of heparin-binding growth factors J Control Release 65 2000 389-402
12. M. Presta D. Leali H. Stabile R. Ronca M. Camozzi L. Coco et al. Heparin derivatives as angiogenesis inhibitors Curr Pharm Des 9 2003 553-566
13. C.A.A. van Boeckel M. Petitou The unique antithrombin III binding domain of heparin: A lead to new synthetic antithrombotics Angew Chem Int Ed Engl 12 1993 1671-1690
14. S. Liekens J. Neyts B. Degrève E. De Clercq The sulfonic acid polymers PAMPS [poly(2-acrylamido-2-methyl-1-propanesulfonic acid)] and related analogs are highly potent inhibitors of angiogenesis Oncol Res 9 1997 173-181
15. S. Liekens D. Leali J. Neyts R. Esnouf M. Rusnati P. Dell'era et al. Modulation of fibroblast growth factor-2 receptor binding, signaling, and mitogenic activity by heparin-mimicking polysulfonated compounds Mol Pharmacol 56 1999 204-213
16. H.Q. Miao D.M. Ornitz E. Aingorn S.A. Ben-Sasson I. Vlodavsky Modulation of fibroblast growth factor-2 receptor binding, dimerization, signaling, and angiogenic activity by a synthetic heparin-mimicking polyanionic compound J Clin Invest 99 1997 1565-1575
17. A. Bentolila I. Vlodavsky C. Haloun A.J. Domb Synthesis and heparin-like biological activity of amino acid-based polymers Polym Adv Technol 11 2000 377-387
18. M. Akashi N. Sakamoto K. Suzuki A. Kishida Synthesis and anticoagulant activity of sulfated glucoside-bearing polymer Bioconjugate Chem 7 1996 393-395
19. R. Guan X.L. Sun S. Hou P. Wu E.L. Chaikof A glycopolymer chaperone for fibroblast growth factor-2 Bioconjugate Chem 15 2004 145-151
20. J. Folkman P.B. Weisz M.M. Joullié W.W. Li W.R. Ewing Control of angiogenesis with synthetic heparin substitutes Science 243 1989 1490-1493
21. R. Danesi S. Del Bianchi P. Soldani A. Campagni R.V. La Rocca C.E. Myers et al. Suramin inhibits bFGF-induced endothelial cell proliferation and angiogenesis in the chick chlorioallantoic membrane Br J Cancer 68 1993 932-938
22. J. Waltenberger U. Mayr H. Frank V. Hombach Suramin is a potent inhibitor of vascular endothelial growth factor. A contribution to the molecular basis of its antiangiogenic action J Mol Cell Cardiol 28 1996 1523-1529
23. F. Manetti V. Capello M. Botta F. Corelli N. Mongelli G. Biasoli et al. Synthesis and binding mode of heterocyclic analogs of suramin inhibiting the human basic fibroblast growth factor Bioorg Med Chem 6 1998 947-958
24. A. Firsching P. Nickel P. Mora B. Allolio Antiproliferative and angiostatic activity of suramin analogues Cancer Res 55 1995 4957-4961
25. K. Ishida M.K. Wierzba T. Teruya S. Simizu H. Osada Novel heparin sulfate mimetic compounds as antitumor agents Chem Biol 11 2004 367-377
26. J. Zhang G. Rivers Y. Zhu A. Jacobson J. Peyers G. Grundstrom et al. Identification of inhibitors of heparin-growth factor interactions from combinatorial libraries of four-component condensation reactions Bioorg Med Chem 9 2001 825-836
27. M. Ueki S. Watanabe Y. Ishii O. Okunaka K. Uchino T. Saitoh et al. Synthesis and anti-HIV activity of nonatyrosine N- and O1-9-decasulfate Bioorg Med Chem 9 2001 477-486
28. M. Ueki S. Watanabe T. Saitoh H. Nakashima N. Yamamoto H. Ogawara Synthesis of chain length-anti-HIV activity relationship of fully N- and O-sulfated homooligomers of tyrosine Bioorg Med Chem 9 2001 487-492
29. K.L. Moore The biology and enzymology of protein tyrosine O-sulfation J Biol Chem 278 2003 24243-24246
30. D. Dormann K.J. Clemetson B.E. Kehrel The GPIb thrombin-binding site is essential for thrombin-induced platelet procoagulant activity Blood 96 2000 2469-2478
31. L. DeMarco M. Mazzucato A. Masotti J.W. Fenton Z.M. Ruggeri Function of glycoprotein Ibα in platelet activation induced by α-thrombin J Biol Chem 266 1991 23776-23783
32. J.J. Dumas R. Kumar J. Seehra W.S. Somers L. Mosyak Crystal structure of the GP1bα-thrombin complex essential for platelet aggregation Science 301 2003 222-226
33. A. Furka F. Sebestyen M. Asgedom G. Dibo General-method for rapid synthesis of multicomponent peptide mixtures Int Peptide Protein Res 37 1991 487-493
34. D.L. Boger J. Desharnais K. Capps Solution-phase combinatorial libraries: Modulating cellular signaling by targeting protein-protein or protein-DNA interactions Angew Chem Int Ed 42 2003 4138-4176
35. K.S. Lam M. Lebl V. Krchňák The "one-bead-one-compound" combinatorial library method Chem Rev 97 1997 411-448
36. G. Lowe Combinatorial chemistry Chem Soc Rev 1995 309-317
37. G. Neufeld T. Cohen S. Gengrinovitch Z. Poltorak Vascular endothelial growth factor (VEGF) and its receptors FASEB J 13 1999 9-22
38. N. Ferrara Vascular endothelial growth factors: Molecular and biological aspects Curr Top Microbiol 237 1999 1-30
39. G.D. Yancopoulos S. Davis N.W. Gale J.S. Rudge S.J. Wiegand J. Holash Vascular-specific growth factors and blood vessel formation Nature 407 2000 242-248
40. P. Carmeliet Mechanisms of angiogenesis and arteriogenesis Nature Med 6 2000 389-395
41. A.J. Singer R.A.F. Clark Cutaneous wound healing New Eng J Med 341 1999 738-746
42. W.J. Fairbrother M.A. Champe H.W. Christinger B.A. Keyt M.A. Starovasnik Solution structure of the heparin-binding domain of vascular endothelial growth factor Structure 6 1998 637-648
43. A.H. Zisch U. Schenk J.C. Schense S.E. Sakiyama-Elbert J.A. Hubbell Covalently conjugated VEGF-fibrin matrices for endothelialization J Control Release 72 2001 101-113
44. L.D. Thompson M.W. Pantoliano B.A. Springer Energetic characterization of the basic fibroblast growth factor-heparin interaction: Identification of the heparin binding domain Biochemistry 33 1994 3831-3840
45. K.S. Lam S.E. Salmon E.M. Hersh V.J. Hruby W.M. Kazmierski R.J. Knapp A new type of synthetic peptide library for identifying ligand-binding activity Nature 354 1991 82-84
46. 3 H)-containing peptides with 9-fluorenylmethyloxycarbonyl (Fmoc)-strategy and its application to the synthesis of cholecystokinin (CCK)-12 Chem Pharm Bull 41 1993 376-380
47. Reprinted from Structure, vol. 6, Fairbrother WJ, Champe MA, Christinger HW, Keyt BA, Starovasnik MA, Solution structure of the heparin-binding domain of vascular endothelial growth factor, pages 644, 1998, with permission from Elsevier.
48. G.T. Hermanson Bioconjugate techniques 1996 Academic Press San Diego, CA
49. K.S. Lam M. Lebl Selectide technology: Bead-binding screening Methods: Compan Methods Enzymol 6 1994 372-380
50. J.M. Maraganore B. Chao M.L. Joesph J. Jablonski K.L. Ramachandran Anticoagulant activity of synthetic hirudin peptides J Biol Chem 264 1989 8692-8698
51. 165 to its receptors Biochem Biophys Res Commun 203 1994 1339-1347
52. S. Faham R.E. Hileman J.R. Fromm R.J. Linhardt D.C. Rees Heparin structure and interactions with basic fibroblast growth factor Science 271 1996 1116-1120
53. T. Yagami K. Kitagawa C. Aida H. Fujiwara S. Futaki Stabilization of a tyrosine O-sulfate residue by a cationic functional group: Formation of a conjugate acid-base pair J Peptide Res 56 2000 239-249
54. T. Young L.L. Kiessling A strategy for the synthesis of sulfated peptides Angew Chem Int Ed 41 2003 3449-3451
55. K. Kitagawa C. Aida H. Fujiwara T. Yagami S. Futaki M. Kogire et al. Facile solid-phase synthesis of sulfated tyrosine-containing peptides: Total synthesis of human big gastrin-II and cholecystokinin (CCK)-39 J Org Chem 66 2001 1-10
56. P. Schuck Use of surface plasmon resonance to probe the equilibrium and dynamic aspects of interactions between biological macromolecules Ann Rev Biophys Biomol Struct 26 1997 541-566
57. A. Huber S. Demartis D. Neri The use of biosensor technology for the engineering of antibodies and enzymes J Mol Recogn 12 1999 198-216
58. P.A. Van der Merwe A.N. Barclay Analysis of cell-adhesion molecule interactions using surface plamon resonance Curr Opin Immunol 8 1996 257-261
59. R. Karlsson A. Fält Experimental design for kinetic analysis of protein-protein interactions with surface plasmon resonance biosensors J Immunol Methods 200 1997 121-133
60. K. Yamamoto C. Ishida Y. Shinohara Y. Hasegawa Y. Konami T. Osawa et. al. Interaction of immobilized recombinant mouse C-type macrophase lectin with glycopeptides and oligosaccharides Biochemistry 33 1994 8159-8166
61. B.A. Keyt L.T. Berleau H.V. Nguyen H. Chen H. Heinsohn R. Vandlen et al. The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency J Biol Chem 271 1996 7788-7795